FDA
-
-
-
-
-
-
-
MediWound (MDWD) Collaborates with MIMEDX (MDXG) on EscharEx Phase III Study
-
-
-
-
-
-
-
MIMEDX Announces Second Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
MiMedx Group (MDXG) Outlines 2022 Key Strategic Milestones
-
-
-
-
-
-
-
MIMEDX Announces Second Quarter 2021 Operating and Financial Results
-
-
-
-
-
-
-
MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results
-
-
-
-
-
-
-
MiMedx Announces Board Approval of Long-Range Strategic Plan
-
-
-
-
-
-
-
MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International
-
251,761 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All